PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)

The Lancet

Volumn 331, Issue 8577, 1988, Pages 76-81

  Yarchoan, Robert ^a   Thomas, RoseV ^a   Allain, Jean Pierre ^b   Mcatee, Nanette ^a   Dubinsky, Richard ^e   Mitsuya, Hiroaki ^a   Lawley, ThomasJ ^a   Safai, Bijan ^f   Myers, CharlesE ^a   Perno, CarloFederico ^a   Klecker, RaymondW ^a   Wills, RobertJ ^c   Fischl, MargaretA ^d   Mcneely, M Carol ^a   Pluda, JamesM ^a   Leuther, Michael ^b   Collins, JerryM ^a   Broder, Samuel ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ABBOTT LABORATORIES   (United States)

^c Hoffmann La Roche   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; CLINICAL ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; THROMBOCYTOPENIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED COMPLEX; COMPARATIVE STUDY; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; DRUG THERAPY, COMBINATION; HIV; HUMAN; MALE; MIDDLE AGE; THYMIDINE; ZALCITABINE; ZIDOVUDINE;

EID: 0023837875     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)90283-8     Document Type: Article

References (15)

1. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex
2. Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine
3. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex A double-blind placebo-controlled trial
4. The toxicity of azidothymidine (AZT) in the treatment of AIDS and AIDS-related complexes. A double-blind, placebo-controlled trial
5. Azidothymidine associated with bone marrow failure in acquired immunodeficiency syndrome (AIDS)
6. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides
7. Initial studies on the cellular pharmacology of 23'-dideoxycytidine and inhibitor of HTLV-III infectivity
8. Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro
9. 2',3'-dideoxynucleosides: broad spectrum antiretroviral activity and mechanism of action
10. A study of the functional capabilities of human neonatal lymphocytes for in vitro specific antibody production
11. The disposition and metabolism of 2',3'-didcoxycytidine, and in vitro inhibitor of HTLV-III infectivity, in mice and monkeys
12. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection
13. Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders
14. Significant changes in HIV antigen level in the serum of patients treated with azidothymidine